
Chemosensors, Journal Year: 2025, Volume and Issue: 13(4), P. 146 - 146
Published: April 16, 2025
The development of cost-effective, rapid-response, and user-friendly biosensing platforms has become paramount importance for achieving precise biomarker quantification in early disease detection. Implementing timely diagnostic interventions through accurate analysis not only significantly improves treatment outcomes but also enables effective management strategies, ultimately leading to substantial reductions patient mortality rates. These clinical imperatives have consequently driven the innovation portable point-of-care (POC) systems. Electrochemical biosensors are attractive diagnosis diseases due their low cost, simple operation, high sensitivity. This review examines prevalent material innovations electrode functionalization electrochemical platforms, with specific emphasis on translational applications early-stage included three important types: proteins, nucleic acids, small molecule metabolites. Furthermore, work proposes novel research trajectories next-generation biosensor development, advocating synergistic integration artificial intelligence-driven analytics, Internet Medical Things (IoMT)-enabled networks, advanced micro/nanofabrication techniques.
Language: Английский